Pseudotumoral cutaneous aspergillosis in chronic granulomatous disease, report of a pediatric case

American Journal of Dermatopathology

Volumn 34, Issue 7, 2012, Pages 749-752

  Khemiri, Monia ^a   El Fekih, Nadia ^b   Borgi, Aida ^a   Kharfi, Monia ^a   Boubaker, Samir ^c   Barsaoui, Sihem ^a  

^a CHILDREN S HOSPITAL   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

^c UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

child; chronic granulomatous disease; invasive aspergillosis; skin

Indexed keywords

COTRIMOXAZOLE; IMMUNOGLOBULIN G; ITRACONAZOLE; PRECIPITIN; VORICONAZOLE;

ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; BLOOD CULTURE; CASE REPORT; CHILD; CHRONIC GRANULOMATOUS DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DISEASE ASSOCIATION; FEMALE; FEVER; FUNGUS HYPHAE; HUMAN; INVASIVE ASPERGILLOSIS; INVASIVE CUTANEOUS ASPERGILLOSIS; LUNG ASPERGILLOSIS; OSTEOMYELITIS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN DEFECT; SKIN INFECTION; SURGICAL DRAINAGE; THORAX RADIOGRAPHY; TREATMENT DURATION;

ANTIFUNGAL AGENTS; BIOPSY; CHILD, PRESCHOOL; DEBRIDEMENT; DERMATOMYCOSES; DRAINAGE; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; OSTEOMYELITIS; SKIN; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 84866743052     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3182562451     Document Type: Article

References (11)

1. Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155-169.
2. Cohen MS, Isturiz RE, Malech HL, et al. Fungal infection in chronic ranulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med. 1981;71:59-66.
3. Lucas GM, Tucker P, Merz WG. Primary cutaneous Aspergillus nidulans infection associated with a Hickman catheter in a patient with neutrope-nia. Clin Infect Dis. 1999;29:1594.
4. Walmsley S, Devi S, King S, et al. Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J. 1993;12:673.
5. Galimberti R, Kowalczuk A, Hidalgo Parraetal I, et al. Cutaneous aspergillosis: a report of six cases. Br J Dermatol. 1998;139:522-526.
6. De Pauwa B, Walsha TJ, Donnellya JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive. Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ MSG) Consensus Group. Clin Infect Dis. 2008;46:1813-1821.
7. Dohil M, Prendiville JS, Crawford RI, et al. Cutaneous disease manifestations of chronic granulomatous disease. A report of four cases and review of the literature. J Am Acad Dermatol. 1997;36:899-907.
8. Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348: 2416-2422.
9. Blumental S, Mouy R, Mahlaoui N, et al. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. Clin Infect Dis. 2011;53:e159-e169.
10. Marcoux D, Jafarian F, Joncas V, et al. Deep cutaneous fungal infections in immunocompromised children. J Am Acad Dermatol. 2009;61: 857-864.
11. Al-Tawfiq JA, Al-Abdely HM. Vertebral osteomyelitis due to Aspergil-lus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma. Med Mycol. 2010;48:537-541.